EUVIMEDEUVIMED entdecken
Crossref

Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment

Er Jin, Zhidong Yin, Xiuxiu Zheng, Chenhong Yan, Kai Xu, Fouejio Yemele Eunice, Yue Gao iD

Journal of Proteome Research · 2024

DOI: 10.1021/acs.jproteome.3c00746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Er Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310002 Zhejiang Pro…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Medical and Health Research Project of Zhejiang Province, Hangzhou Science and Technology Bureau, Construction Fund of Key Medical Disciplines of Hangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tryptophan catabolism plays an important role in the metabolic reconnection in cancer cells to support special demands of tumor initiation and progression. The catabolic product of the tryptophan pathway, kynurenine, has the capability of suppressing the immune reactions of tumor cells. In this study, we conducted internal and external cohort studies to reveal the importance of tryptophan 2,3-dioxygenase (TDO) for lung adenocarcinoma (LUAD). Our study further demonstrated that the TDO2 expression was associated with the proliferation, survival, and invasion of LUAD cells, and targeting TDO2 for LUAD tumors could be a potential therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsHumansTryptophan OxygenaseTryptophanKynurenine

Stichwörter der Autor:innen

invasionlung adenocarcinomametabolismproliferationtryptophan 2,3-dioxygenase

Substanzen

Tryptophan OxygenaseTryptophanKynurenine

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310002 Zhejiang Province, China.
  • Department of Pathology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009 Zhejiang Province, China.
  • Department of Geriatric, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006 Zhejiang Province, China.
  • Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for the Prevention and Treatment of Major Chronic Disease in the Elderly, Hangzhou 310006 Zhejiang Province, China.

ORCID-Profile: Yue Gao

Förderung

  • Medical and Health Research Project of Zhejiang Province
  • Hangzhou Science and Technology Bureau
  • Construction Fund of Key Medical Disciplines of Hangzhou
  • Zhejiang Province Nature Science Funding Commission Social Development Project

Zitieren

APA

Jin, E., Yin, Z., Zheng, X., Yan, C., Xu, K., Eunice, F. Y., & Gao, Y. (2024). Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.3c00746

Vancouver

Jin E, Yin Z, Zheng X, Yan C, Xu K, Eunice FY, et al. Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.3c00746

BibTeX
@article{Jin2024,
  author = {Jin, Er and Yin, Zhidong and Zheng, Xiuxiu and Yan, Chenhong and Xu, Kai and Eunice, Fouejio Yemele and Gao, Yue},
  title = {Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment},
  journal = {Journal of Proteome Research},
  year = {2024},
  doi = {10.1021/acs.jproteome.3c00746}
}
Kostenlos starten →